IM
Healthcare & Life Sciences
Inno Medicine
Inno Medicine is a Healthcare & Life Sciences startup based in China, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
2016
Founded
1
Investors
About Inno Medicine
Based in China, Inno Medicine is a startup founded in 2016. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Inno Medicine develops liposome-based active targeting nano-drug delivery platforms and targeted diagnostic and therapeutic products addressing diseases with unmet clinical needs, including a proprietary treatment for atherosclerosis currently in clinical trials in the US and China.
Explore Inno Medicine's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.